Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 57 (2023): Issue 2 (June 2023)
Open Access
Association between
PIK3CA
activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy
Domen Ribnikar
Domen Ribnikar
,
Valentina Jeric Horvat
Valentina Jeric Horvat
,
Ivica Ratosa
Ivica Ratosa
,
Zachary W Veitch
Zachary W Veitch
,
Biljana Grcar Kuzmanov
Biljana Grcar Kuzmanov
,
Srdjan Novakovic
Srdjan Novakovic
,
Erik Langerholc
Erik Langerholc
,
Eitan Amir
Eitan Amir
and
Bostjan Seruga
Bostjan Seruga
| Jun 21, 2023
Radiology and Oncology
Volume 57 (2023): Issue 2 (June 2023)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Jun 21, 2023
Page range:
220 - 228
Received:
Feb 13, 2023
Accepted:
May 18, 2023
DOI:
https://doi.org/10.2478/raon-2023-0027
Keywords
invasive lobular carcinoma
,
PIK3CA mutation
,
endocrine therapy
,
genomics of invasive lobular carcinoma
© 2023 Domen Ribnikar et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Domen Ribnikar
Department of Medical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Faculty of Medicine Ljubljana, University of Ljubljana
Ljubljana, Slovenia
Valentina Jeric Horvat
Department of Medical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Ivica Ratosa
Faculty of Medicine Ljubljana, University of Ljubljana
Ljubljana, Slovenia
Department of Radiation Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Zachary W Veitch
Division of Medical Oncology and Hematology, Royal Victoria Hospital
Bariie, USA
Biljana Grcar Kuzmanov
Department of Pathology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Srdjan Novakovic
Department of Molecular Diagnostics, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Erik Langerholc
Institute of Biostatistics and informatics, Faculty of Medicine Ljubljana, University of Ljubljana
Ljubljana, Slovenia
Eitan Amir
Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre
Toronto, Canada
Bostjan Seruga
Department of Medical Oncology, Institute of Oncology Ljubljana
Ljubljana, Slovenia
Faculty of Medicine Ljubljana, University of Ljubljana
Ljubljana, Slovenia